xanthine derivatives (Aventis)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namexanthine derivatives (Aventis)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionBone resorption inhibitors

TargetsUpdating

Therapy Area/IndicationsOsteoporosisBone Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAventis Pharma Sa

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAventis Pharma Sa

Active IndicationsN/A

Inactive IndicationsOsteoporosisBone Diseases

ATC CodeN/A